Catheters Market - Global Forecast to 2030
商品番号 : SMB-86187
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 416 |
| 図表数 | 522 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、カテーテル市場を種類、適応症、エンドユーザー、地域の観点から分析しています。また、市場の成長要因（成長促進要因、阻害要因、機会、課題）についても分析しています。さらに、市場の機会と課題を分析し、市場リーダーの競争環境を詳細に分析しています。さらに、ミクロ市場の成長傾向を分析し、5つの主要地域と各国における市場セグメントの収益予測も行っています。
カテーテル市場は、心臓血管、泌尿器、神経学の各分野における画像誘導および低侵襲カテーテルを用いた処置の導入増加を背景に、着実な成長が見込まれています。操縦可能なカテーテルや圧力感受性カテーテル、薬剤コーティング技術、抗菌コーティングといった革新的な技術は、処置の成果を向上させ、合併症率を低減します。さらに、心臓血管および神経学におけるAIを活用したナビゲーションとリアルタイムイメージングの導入増加は、特に複雑な症例において、処置の精度を向上させます。さらに、高度な介入を可能にする三次医療現場におけるハイブリッド手術室やカテーテルラボの開発も、需要をさらに押し上げています。これらの専門的な進歩は、特に処置件数の増加や生活習慣病の増加に直面している地域において、市場の着実な成長軌道を推進しています。
The catheters market is projected to grow steadily, driven by the increasing adoption of image-guided and minimally invasive catheter-based procedures across cardiovascular, urological, and neurological applications. Innovations such as steerable and pressure-sensitive catheters, drug-coated technologies, and antimicrobial coatings improve procedural outcomes and reduce complication rates. Additionally, the rising deployment of AI-powered navigation and real-time imaging in interventional cardiology and neurology enhances procedural precision, particularly in complex cases. Demand is further fueled by the development of hybrid operating rooms and catheter labs in tertiary care settings, enabling advanced interventions. These specialized advancements propel the market’s consistent growth trajectory, especially in regions facing high procedural volumes and increasing lifestyle-related diseases.
“By type, the cardiovascular catheters segment accounted for the largest market in 2024.”
The cardiovascular catheters segment accounted for the largest market in 2024, and this trend is projected to continue during the forecast period. The growth of this segment is fueled by the increasing incidence of heart conditions, such as coronary artery disease, heart failure, and arrhythmias, particularly among older adults, often requiring minimally invasive procedures like angioplasty and ablation, which involve the use of catheters. Advancements in catheter technologies, including drug-eluting and imaging-compatible catheters, have improved procedure safety and outcomes. Additionally, the rising awareness of people regarding early cardiac care and favorable reimbursement policies is driving continuous R&D investments by key players, further boosting the segment’s growth.
“By end user, the hospitals segment accounted for the largest share in the catheters market in 2024.”
The hospitals segment accounted for the largest share of the global catheters market in 2024. The segment’s position can be attributed to the high volume of procedures performed in these settings and the availability of advanced medical infrastructure. Hospitals handle various catheter-based treatments, including cardiovascular, urinary, and neurological procedures requiring skilled professionals and specialized equipment. The rising number of inpatient admissions for chronic conditions, such as heart disease and kidney disorders, is also contributing to this demand. Hospitals are better equipped to adopt advanced catheter technologies and ensure proper infection control practices. Additionally, many countries’ strong reimbursement support for hospital-based procedures further boosts utilization. All these factors collectively make hospitals the largest end users of catheters.
“North America accounted for the largest share of the global catheters market in 2024.”
North America accounted for the largest market in the global catheters market, mainly due to its advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative medical technologies. Additionally, the region sees a high prevalence of chronic diseases like cardiovascular disorders, kidney failure, and urinary incontinence, which significantly drives the demand for various catheter types. Moreover, leading catheter manufacturers, strong distribution networks, and well-established reimbursement policies support widespread usage across hospitals, clinics, and ambulatory surgical centers. Favorable regulatory approvals, growing preference for minimally invasive procedures, and rising geriatric population further boost the market. These combined factors make North America the dominant global catheter market in the region.
Breakdown of Supply-side Primary Interviews:
- By Company Type: Tier 1 – 45%, Tier 2 – 20%, and Tier 3 – 35%
- By Designation: C-level Executives – 35%, Directors – 25%, and Other Designations – 40%
- By Region: North America – 40%, Europe – 25%, Asia Pacific – 20%, Latin America – 10%, Middle East & Africa – 5%
Research Coverage
This report studies the catheters market in terms of type, indication, end user, and region. It also studies market growth factors (drivers, restraints, opportunities, and challenges). The report further analyzes the market’s opportunities and challenges and details the competitive landscape for market leaders. It analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments concerning five main regions and respective countries.
Reasons to Buy the Report
The report can help established and new entrants/smaller firms gauge the market’s pulse, which, in turn, would help them garner a greater share. The report provides insights into the following pointers:
- Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the catheters market
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the catheters market
- Market Development: Comprehensive information about lucrative emerging markets across regions
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the catheters market
- Competitive Assessment: In-depth assessment of market share, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the catheters market
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 MARKETS COVERED 35
1.2.2 INCLUSIONS & EXCLUSIONS 36
1.2.3 YEARS CONSIDERED 37
1.3 CURRENCY 37
1.4 UNIT CONSIDERED 37
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
2.1.1 SECONDARY DATA 40
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 42
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 45
2.2 MARKET SIZE ESTIMATION 47
2.2.1 TOP-DOWN APPROACH 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
2.4 MARKET SHARE ESTIMATION 53
2.5 STUDY ASSUMPTIONS 54
2.6 RISK ASSESSMENT 54
2.7 RESEARCH LIMITATIONS 55
2.7.1 METHODOLOGY-RELATED LIMITATIONS 55
2.7.2 SCOPE-RELATED LIMITATIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 63
4.1 CATHETERS MARKET OVERVIEW 63
4.2 NORTH AMERICA: CATHETERS MARKET OVERVIEW 64
4.3 CATHETERS MARKET: REGIONAL MIX 65
4.4 CATHETERS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 65
4.5 CATHETERS MARKET: DEVELOPING VS. DEVELOPED MARKETS 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
5.2.1 DRIVERS 68
5.2.1.1 Rising geriatric population 68
5.2.1.2 Increasing prevalence of chronic diseases 68
5.2.1.3 Increased awareness and treatment of urinary incontinence 69
5.2.1.4 Rising demand for minimally invasive surgeries 69
5.2.2 RESTRAINTS 70
5.2.2.1 Product recalls and failures 70
5.2.2.2 Presence of substitute medical devices 70
5.2.3 OPPORTUNITIES 71
5.2.3.1 Growing demand in emerging markets 71
5.2.3.2 Technological advancements and product innovation 71
5.2.4 CHALLENGES 72
5.2.4.1 Integration complexity with existing production lines 72
5.3 TECHNOLOGY ANALYSIS 73
5.3.1 KEY TECHNOLOGIES 73
5.3.1.1 Antimicrobial-coated catheters 73
5.3.1.2 Drug-eluting catheters 73
5.3.2 COMPLEMENTARY TECHNOLOGIES 73
5.3.2.1 Hydrophilic coatings for catheters 73
5.3.2.2 Ultrasound-guided insertion systems 74
5.3.3 ADJACENT TECHNOLOGIES 74
5.3.3.1 Minimally invasive surgical devices 74
5.4 PORTER’S FIVE FORCES ANALYSIS 75
5.4.1 INTENSITY OF COMPETITIVE RIVALRY 76
5.4.2 BARGAINING POWER OF BUYERS 76
5.4.3 BARGAINING POWER OF SUPPLIERS 76
5.4.4 THREAT OF SUBSTITUTES 76
5.4.5 THREAT OF NEW ENTRANTS 77
5.5 REGULATORY LANDSCAPE 77
5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
5.5.2 REGULATORY FRAMEWORK 79
5.5.2.1 North America 79
5.5.2.1.1 US 79
5.5.2.1.2 Canada 81
5.5.2.2 Europe 81
5.5.2.3 Asia Pacific 81
5.5.2.3.1 China 81
5.5.2.3.2 Japan 81
5.5.2.3.3 India 81
5.5.2.4 Latin America 82
5.5.2.4.1 Brazil 82
5.5.2.4.2 Mexico 82
5.5.2.5 Middle East 82
5.5.2.6 Africa 83
5.6 PATENT ANALYSIS 83
5.6.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS AND JURISDICTION FOR CATHETERS MARKET, JANUARY 2015–DECEMBER 2025 83
5.6.2 LIST OF MAJOR PATENTS, 2023–2024 85
5.7 TRADE ANALYSIS 86
5.7.1 IMPORT DATA FOR HS CODE 901839, 2020–2024 86
5.7.2 EXPORT DATA FOR HS CODE 901839, 2020–2024 87
5.8 REIMBURSEMENT SCENARIO 87
5.9 KEY CONFERENCES & EVENTS, 2025–2026 89
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
5.10.2 KEY BUYING CRITERIA 91
5.11 PRICING ANALYSIS 92
5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE, 2022–2024 92
5.11.2 AVERAGE SELLING PRICE TREND OF CATHETERS, BY REGION, 2022–2024 93
5.12 VALUE CHAIN ANALYSIS 94
5.13 ECOSYSTEM ANALYSIS 95
5.14 IMPACT OF AI/GEN AI ON CATHETERS MARKET 96
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 97
5.16 INVESTMENT & FUNDING SCENARIO 98
5.17 CATHETERS MARKET: IMPACT OF 2025 US TARIFF 98
5.17.1 INTRODUCTION 98
5.17.2 KEY TARIFF RATES 99
5.17.3 PRICE IMPACT ANALYSIS 99
5.17.4 IMPACT ON COUNTRY/REGION 100
5.17.4.1 North America 100
5.17.4.2 Europe 100
5.17.4.3 Asia Pacific 100
5.17.5 IMPACT ON END USERS 101
5.17.5.1 Hospitals 101
5.17.5.2 Ambulatory surgical centers 101
5.17.5.3 Long-term care facilities 101
5.17.5.4 Diagnostic imaging centers 101
5.17.5.5 Outpatient clinics 101
5.17.5.6 Other end users 101
6 CATHETERS MARKET, BY TYPE 102
6.1 INTRODUCTION 103
6.2 CARDIOVASCULAR CATHETERS 103
6.2.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES AND GROWING INTERVENTIONAL PROCEDURES TO FUEL DEMAND 103
6.2.2 ELECTROPHYSIOLOGY CATHETERS 105
6.2.2.1 Increasing prevalence of atrial fibrillation and expansion of electrophysiology labs to drive segment 105
6.2.3 ANGIOGRAPHY CATHETERS 107
6.2.3.1 Growing use of minimally invasive diagnostics and better imaging outcomes to propel growth 107
6.2.4 CORONARY BALLOON CATHETERS 108
6.2.4.1 Rapid growth in percutaneous coronary interventions and technological innovation to support growth 108
6.2.5 IVUS/OCT CATHETERS 110
6.2.5.1 Integration of intravascular imaging into PCI and clinical guidelines to drive uptake 110
6.2.6 GUIDING CATHETERS 111
6.2.6.1 Versatility in access and support during complex interventions to boost demand 111
6.2.7 OTHER CARDIOVASCULAR CATHETERS 112
6.3 INTRAVENOUS CATHETERS 114
6.3.1 INCREASING USE IN LONG-TERM THERAPIES AND HOSPITAL-ACQUIRED INFECTION PREVENTION EFFORTS TO DRIVE GROWTH 114
6.3.2 GLOBAL VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 114
6.3.3 CENTRAL VENOUS CATHETERS 116
6.3.3.1 Rising use in intensive and emergency care, along with multi-lumen design advancements, to drive demand 116
6.3.3.2 Peripherally inserted central catheters 117
6.3.3.2.1 Preference for long-term, outpatient IV therapy and reduced complication rates to drive use 117
6.3.3.3 Non-tunneled central venous catheters 119
6.3.3.3.1 Immediate access in emergency and ICU settings supports continued use 119
6.3.3.4 Skin-tunneled central venous catheters 120
6.3.3.4.1 Low infection risk and suitability for long-term therapies drive adoption 120
6.3.3.5 Implantable ports 122
6.3.3.5.1 Rise in cancer prevalence and demand for discreet, low-maintenance access devices drive use 122
6.3.4 PERIPHERAL INTRAVENOUS CATHETERS 123
6.3.4.1 High frequency of use and cost-effectiveness drive widespread adoption 123
6.3.5 MIDLINE PERIPHERAL CATHETERS 125
6.3.5.1 Rising preference in infection-prone patients and long-duration therapies to fuel market growth 125
6.4 UROLOGICAL CATHETERS 127
6.4.1 AGING POPULATION AND RISE IN RENAL AND UROLOGICAL DISORDERS TO DRIVE DEMAND 127
6.4.2 URINARY CATHETERS 129
6.4.2.1 Rising geriatric population and increased incidence of urinary incontinence – key drivers of growth 129
6.4.2.2 Indwelling catheters 130
6.4.2.2.1 Hospital-acquired urinary retention cases and long-term catheterization needs to drive demand 130
6.4.2.3 Intermittent catheters 131
6.4.2.3.1 Rising preference for self-catheterization and reduced infection risk accelerates adoption 131
6.4.2.4 External catheters 133
6.4.2.4.1 Growing use of non-invasive options in female and bedridden patients to fuel demand 133
6.4.3 DIALYSIS CATHETERS 135
6.4.3.1 Rising prevalence of end-stage renal disease and need for immediate vascular access to drive use 135
6.4.3.2 Peritoneal dialysis catheters 136
6.4.3.2.1 Preference for home-based renal therapy to support segment growth 136
6.4.3.3 Hemodialysis catheters 137
6.4.3.3.1 Increasing prevalence of end-stage renal disease and urgency for rapid vascular access to drive demand 137
6.5 SPECIALTY CATHETERS 139
6.5.1 DIVERSE CLINICAL UTILITY AND ADVANCEMENTS IN MINIMALLY INVASIVE MONITORING TO SUPPORT GROWTH 139
6.5.2 PRESSURE & HEMODYNAMIC CATHETERS 140
6.5.2.1 Precision in critical care and expanding cardiac monitoring – key drivers 140
6.5.3 TEMPERATURE MONITORING CATHETERS 142
6.5.3.1 Segment to gain traction due to need for precise core temperature control in critical illness 142
6.5.4 INTRAUTERINE INSEMINATION CATHETERS 143
6.5.4.1 Rising use of assisted reproduction and favorable clinical outcomes support growth of segment 143
6.5.5 OTHER SPECIALTY CATHETERS 145
6.6 NEUROVASCULAR CATHETERS 146
6.6.1 INCREASING STROKE BURDEN AND SHIFT TOWARD ENDOVASCULAR THERAPY TO ACCELERATE DEMAND 146
7 CATHETERS MARKET, BY INDICATION 148
7.1 INTRODUCTION 149
7.2 CARDIAC DISEASES 149
7.2.1 GROWING CARDIOVASCULAR DISEASE BURDEN TO DRIVE DOMINANCE OF SEGMENT 149
7.3 NEUROVASCULAR CONDITIONS 150
7.3.1 INCREASING STROKE INCIDENCE AND ADVANCED NEURO-INTERVENTION TECHNIQUES TO FUEL SEGMENT 150
7.4 URINARY CONDITIONS 152
7.4.1 RISING CASES OF URINARY INCONTINENCE AND UROLOGICAL DISORDERS TO DRIVE DEMAND 152
7.5 VASCULAR DISEASES 153
7.5.1 PREVALENCE OF PERIPHERAL ARTERY DISEASE AND DEEP VEIN THROMBOSIS AIDS GROWTH OF SEGMENT 153
7.6 IV MEDICATION DELIVERY & FLUID MANAGEMENT 155
7.6.1 GROWING USE OF LONG-TERM IV THERAPY IN CHRONIC CONDITIONS TO SUPPORT EXPANSION OF SEGMENT 155
7.7 KIDNEY DISEASES 156
7.7.1 HIGH GLOBAL BURDEN OF END-STAGE RENAL DISEASE TO ACCELERATE GROWTH 156
7.8 BLOOD TRANSFUSION 158
7.8.1 INCREASE IN SURGICAL VOLUME AND CRITICAL CARE NEEDS TO DRIVE DEMAND 158
7.9 OTHER INDICATIONS 159
8 CATHETERS MARKET, BY END USER 161
8.1 INTRODUCTION 162
8.2 HOSPITALS 162
8.2.1 RAPID EXPANSION OF HOSPITAL CAPACITY AND INFRASTRUCTURE TO DRIVE MARKET 162
8.3 AMBULATORY SURGICAL CENTERS 163
8.3.1 SURGE IN OUTPATIENT PROCEDURES AND REGULATORY SUPPORT TO SPUR GROWTH 163
8.4 LONG-TERM CARE FACILITIES 164
8.4.1 AGING POPULATION AND ASSISTED LIVING DEMAND INCREASED CATHETER USE 164
8.5 DIAGNOSTIC IMAGING CENTERS 166
8.5.1 HIGH VOLUME OF IMAGING PROCEDURES BOOSTS CATHETER DEMAND 166
8.6 OUTPATIENT CLINICS 167
8.6.1 RISING OUTPATIENT VISIT VOLUMES AND PROCEDURAL SHIFT INCREASE CATHETER USE 167
8.7 OTHER END USERS 168
9 CATHETERS MARKET, BY REGION 169
9.1 INTRODUCTION 170
9.2 NORTH AMERICA 171
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171
9.2.2 NORTH AMERICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 174
9.2.3 US 177
9.2.3.1 Rising chronic disease burden spurs innovation demand in catheter use 177
9.2.4 CANADA 182
9.2.4.1 Aging population and rising hypertension & urinary conditions lift catheter demand 182
9.3 EUROPE 187
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 187
9.3.2 EUROPE: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 189
9.3.3 GERMANY 192
9.3.3.1 Aging population and high PCI volume to drive catheter usage 192
9.3.4 UK 196
9.3.4.1 High prevalence of long‑term urinary catheter use maintained by community nursing demand 196
9.3.5 FRANCE 200
9.3.5.1 Widespread use of intermittent urinary catheters to support second-largest share 200
9.3.6 SPAIN 204
9.3.6.1 Rising UTI burden in nursing homes boosts urinary catheter demand 204
9.3.7 ITALY 208
9.3.7.1 Recent heightened CAUTI risk in ICUs underpins demand for safer urinary catheters 208
9.3.8 REST OF EUROPE 212
9.4 ASIA PACIFIC 216
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 216
9.4.2 ASIA PACIFIC VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 218
9.4.3 JAPAN 222
9.4.3.1 Aging population and rising cardiovascular care needs to boost demand for catheters 222
9.4.4 CHINA 226
9.4.4.1 High cardiovascular disease burden and expanding care access to drive demand 226
9.4.5 INDIA 230
9.4.5.1 Set to be fastest‑growing market with escalating CVD incidence 230
9.4.6 AUSTRALIA 234
9.4.6.1 High cardiovascular disease burden and strong government support to drive growth 234
9.4.7 SOUTH KOREA 239
9.4.7.1 Rising arrhythmia treatments and expanding interventional cardiology infrastructure bolster catheter demand 239
9.4.8 REST OF ASIA PACIFIC 243
9.5 LATIN AMERICA 248
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 248
9.5.2 LATIN AMERICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 250
9.5.3 BRAZIL 253
9.5.3.1 Robust public healthcare infrastructure and high cardiovascular procedure volume drive dominance 253
9.5.4 MEXICO 258
9.5.4.1 High diabetes and cardiovascular disease prevalence spurs catheter demand 258
9.5.5 REST OF LATIN AMERICA 262
9.6 MIDDLE EAST & AFRICA 267
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 267
9.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 269
9.6.3 GCC COUNTRIES 273
9.6.3.1 Market uplift through strategic healthcare investments and rising procedure volumes 273
9.6.3.2 Kingdom of Saudi Arabia (KSA) 277
9.6.3.2.1 Market gains strength from healthcare transformation and NCD burden 277
9.6.3.3 United Arab Emirates (UAE) 282
9.6.3.3.1 Market growth anchored in advanced hospital infrastructure and medical tourism 282
9.6.3.4 Other GCC Countries 286
9.6.4 REST OF MIDDLE EAST & AFRICA 290
10 COMPETITIVE LANDSCAPE 294
10.1 OVERVIEW 294
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 294
10.3 REVENUE ANALYSIS OF KEY PLAYERS IN CATHETERS MARKET (2022–2024) 296
10.4 MARKET SHARE ANALYSIS 297
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 298
10.5.1 STARS 298
10.5.2 EMERGING LEADERS 299
10.5.3 PERVASIVE PLAYERS 299
10.5.4 PARTICIPANTS 299
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 300
10.5.5.1 Company footprint 300
10.5.5.2 Region footprint 301
10.5.5.3 Type footprint 302
10.5.5.4 Indication footprint 303
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 304
10.6.1 PROGRESSIVE COMPANIES 304
10.6.2 DYNAMIC COMPANIES 304
10.6.3 STARTING BLOCKS 304
10.6.4 RESPONSIVE COMPANIES 304
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 306
10.6.5.1 Detailed list of key startups/SMEs 306
10.6.5.2 Competitive benchmarking of key emerging players/startups 307
10.7 BRAND/PRODUCT COMPARISON 308
10.8 R&D EXPENDITURE OF KEY PLAYERS 308
10.9 COMPANY VALUATION & FINANCIAL METRICS 309
10.9.1 COMPANY VALUATION 309
10.9.2 FINANCIAL METRICS 309
10.10 COMPETITIVE SCENARIO 310
10.10.1 PRODUCT APPROVALS/LAUNCHES 310
10.10.2 DEALS 311
10.10.3 EXPANSIONS 312
10.10.4 OTHER DEVELOPMENTS 313
11 COMPANY PROFILES 314
11.1 KEY PLAYERS 314
11.1.1 BOSTON SCIENTIFIC CORPORATION 314
11.1.1.1 Business overview 314
11.1.1.2 Products offered 315
11.1.1.3 Recent developments 318
11.1.1.3.1 Product launches & approvals 318
11.1.1.3.2 Deals 319
11.1.1.4 MnM view 319
11.1.1.4.1 Right to win 319
11.1.1.4.2 Strategic choices 319
11.1.1.4.3 Weaknesses and competitive threats 320
11.1.2 MEDTRONIC PLC 321
11.1.2.1 Business overview 321
11.1.2.2 Products offered 322
11.1.2.3 Recent developments 324
11.1.2.3.1 Product launches & approvals 324
11.1.2.3.2 Deals 324
11.1.2.4 MnM view 325
11.1.2.4.1 Right to win 325
11.1.2.4.2 Strategic choices 325
11.1.2.4.3 Weaknesses and competitive threats 325
11.1.3 B. BRAUN SE 326
11.1.3.1 Business overview 326
11.1.3.2 Products offered 327
11.1.3.3 Recent developments 329
11.1.3.3.1 Deals 329
11.1.3.3.2 Expansions 329
11.1.3.4 MnM view 329
11.1.3.4.1 Right to win 329
11.1.3.4.2 Strategic choices 330
11.1.3.4.3 Weaknesses and competitive threats 330
11.1.4 BECTON, DICKINSON AND COMPANY 331
11.1.4.1 Business overview 331
11.1.4.2 Products offered 332
11.1.4.3 Recent developments 334
11.1.4.3.1 Product launches & approvals 334
11.1.4.3.2 Deals 334
11.1.4.3.3 Expansions 334
11.1.4.4 MnM view 335
11.1.4.4.1 Right to win 335
11.1.4.4.2 Strategic choices 335
11.1.4.4.3 Weaknesses and competitive threats 335
11.1.5 STRYKER CORPORATION 336
11.1.5.1 Business overview 336
11.1.5.2 Products offered 337
11.1.5.3 Recent developments 338
11.1.5.3.1 Product launches & approvals 338
11.1.5.3.2 Deals 338
11.1.5.4 MnM view 339
11.1.5.4.1 Right to win 339
11.1.5.4.2 Strategic choices 339
11.1.5.4.3 Weaknesses and competitive threats 339
11.1.6 ABBOTT LABORATORIES 340
11.1.6.1 Business overview 340
11.1.6.2 Products offered 341
11.1.6.3 Recent developments 342
11.1.6.3.1 Product launches & approvals 342
11.1.6.3.2 Deals 343
11.1.6.3.3 Other developments 343
11.1.7 TERUMO CORPORATION 344
11.1.7.1 Business overview 344
11.1.7.2 Products offered 345
11.1.7.3 Recent developments 346
11.1.7.3.1 Product launches & approvals 346
11.1.7.3.2 Deals 347
11.1.7.3.3 Expansions 347
11.1.8 COLOPLAST A/S 348
11.1.8.1 Business overview 348
11.1.8.2 Products offered 349
11.1.8.3 Recent developments 351
11.1.8.3.1 Product launches & approvals 351
11.1.8.3.2 Expansions 351
11.1.9 CONVATEC GROUP PLC 352
11.1.9.1 Business overview 352
11.1.9.2 Products offered 354
11.1.9.3 Recent developments 354
11.1.9.3.1 Product launches & approvals 354
11.1.10 MERIT MEDICAL SYSTEMS, INC. 355
11.1.10.1 Business overview 355
11.1.10.2 Products offered 356
11.1.10.3 Recent developments 358
11.1.10.3.1 Product launches & approvals 358
11.1.10.3.2 Deals 358
11.1.11 JOHNSON & JOHNSON 359
11.1.11.1 Business overview 359
11.1.11.2 Products offered 360
11.1.11.3 Recent developments 361
11.1.11.3.1 Product launches & approvals 361
11.1.11.3.2 Deals 363
11.1.12 COOK 364
11.1.12.1 Business overview 364
11.1.12.2 Products offered 364
11.1.12.3 Recent developments 366
11.1.12.3.1 Product launches & approvals 366
11.1.12.3.2 Deals 366
11.1.13 EDWARDS LIFESCIENCES CORPORATION 367
11.1.13.1 Business overview 367
11.1.13.2 Products offered 368
11.1.14 NIPRO CORPORATION 369
11.1.14.1 Business overview 369
11.1.14.2 Products offered 370
11.1.14.3 Recent developments 371
11.1.14.3.1 Expansions 371
11.1.15 TELEFLEX INCORPORATED 372
11.1.15.1 Business overview 372
11.1.15.2 Products offered 373
11.1.15.3 Recent developments 375
11.1.15.3.1 Product launches & approvals 375
11.1.15.3.2 Deals 375
11.1.16 CARDINAL HEALTH, INC. 376
11.1.16.1 Business overview 376
11.1.16.2 Products offered 377
11.1.16.3 Recent developments 378
11.1.16.3.1 Expansions 378
11.1.17 HOLLISTER INCORPORATED 379
11.1.17.1 Business overview 379
11.1.17.2 Products offered 379
11.1.17.3 Recent developments 380
11.1.17.3.1 Expansions 380
11.1.18 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 381
11.1.18.1 Business overview 381
11.1.18.2 Products offered 382
11.1.19 KONINKLIJKE PHILIPS N.V. 384
11.1.19.1 Business overview 384
11.1.19.2 Products offered 385
11.1.19.3 Recent developments 386
11.1.19.3.1 Expansions 386
11.1.20 MICROPORT SCIENTIFIC CORPORATION 387
11.1.20.1 Business overview 387
11.1.20.2 Products offered 389
11.1.20.3 Recent developments 389
11.1.20.3.1 Product launches & approvals 389
11.2 OTHER PLAYERS 391
11.2.1 AMECATH 391
11.2.2 SIS MEDICAL AG 392
11.2.3 ANGIPLAST PRIVATE LIMITED 393
11.2.4 RELISYS MEDICAL DEVICES LIMITED 394
11.2.5 CAGENT VASCULAR 395
11.2.6 BIOTRONIK 396
11.2.7 ADVIN HEALTH CARE 398
11.2.8 ALVIMEDICA 399
11.2.9 INGENION MEDICAL LIMITED 400
11.2.10 SUMMA THERAPEUTICS, LLC 401
12 APPENDIX 402
12.1 DISCUSSION GUIDE 402
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 411
12.3 CUSTOMIZATION OPTIONS 413
12.3.1 PRODUCT ANALYSIS 413
12.3.2 GEOGRAPHIC ANALYSIS 413
12.3.3 COMPANY INFORMATION 413
12.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 413
12.3.5 COUNTRY-LEVEL VOLUME ANALYSIS 413
12.3.6 PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 413
12.3.7 ANY CONSULTS/CUSTOM STUDIES AS PER CLIENT REQUIREMENTS 413
12.4 RELATED REPORTS 414
12.5 AUTHOR DETAILS 415
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 37
TABLE 2 CATHETERS MARKET: STUDY ASSUMPTION ANALYSIS 54
TABLE 3 CATHETERS MARKET: RISK ASSESSMENT ANALYSIS 54
TABLE 4 CATHETERS MARKET: PORTER’S FIVE FORCES 75
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION 80
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 80
TABLE 12 CATHETERS MARKET: KEY PATENTS, JANUARY 2023–DECEMBER 2024 85
TABLE 13 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD MILLION) 86
TABLE 14 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD MILLION) 87
TABLE 15 CATHETERS MARKET: KEY CONFERENCES & EVENTS, JULY 2025−JUNE 2026 89
TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 90
TABLE 17 KEY BUYING CRITERIA FOR CATHETERS 91
TABLE 18 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY CATHETER TYPE,
2022–2024 (USD) 92
TABLE 19 AVERAGE SELLING PRICE OF CATHETERS, BY REGION, 2022–2024 (USD) 93
TABLE 20 CATHETERS MARKET: IMPACT OF AI/GEN AI 96
TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 99
TABLE 22 CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 103
TABLE 23 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 104
TABLE 24 CARDIOVASCULAR CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 105
TABLE 25 ELECTROPHYSIOLOGY CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 106
TABLE 26 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 108
TABLE 27 CORONARY BALLOON CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 109
TABLE 28 IVUS/OCT CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 111
TABLE 29 GUIDING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 112
TABLE 30 OTHER CARDIOVASCULAR CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 113
TABLE 31 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS) 114
TABLE 32 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 115
TABLE 33 INTRAVENOUS CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 115
TABLE 34 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 116
TABLE 35 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 117
TABLE 36 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 118
TABLE 37 NON-TUNNELED CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 120
TABLE 38 SKIN-TUNNELED CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 121
TABLE 39 IMPLANTABLE PORTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 123
TABLE 40 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 124
TABLE 41 MIDLINE PERIPHERAL CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 126
TABLE 42 UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127
TABLE 43 UROLOGICAL CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 128
TABLE 44 URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129
TABLE 45 URINARY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 130
TABLE 46 INDWELLING CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 131
TABLE 47 INTERMITTENT CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 132
TABLE 48 EXTERNAL CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 134
TABLE 49 DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135
TABLE 50 DIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 136
TABLE 51 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 137
TABLE 52 HEMODIALYSIS CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 138
TABLE 53 SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139
TABLE 54 SPECIALTY CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 140
TABLE 55 PRESSURE & HEMODYNAMIC CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 141
TABLE 56 TEMPERATURE MONITORING CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 143
TABLE 57 INTRAUTERINE INSEMINATION CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 144
TABLE 58 OTHER SPECIALTY CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 145
TABLE 59 NEUROVASCULAR CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 147
TABLE 60 CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 149
TABLE 61 CARDIAC DISEASES: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 150
TABLE 62 NEUROVASCULAR CONDITIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 151
TABLE 63 URINARY CONDITIONS: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 153
TABLE 64 VASCULAR DISEASES: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 154
TABLE 65 IV MEDICATION DELIVERY & FLUID MANAGEMENT: CATHETERS MARKET,
BY COUNTRY/REGION, 2023–2030 (USD MILLION) 156
TABLE 66 KIDNEY DISEASES: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 157
TABLE 67 BLOOD TRANSFUSION: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 159
TABLE 68 OTHER INDICATIONS: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 160
TABLE 69 CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 162
TABLE 70 HOSPITALS: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 163
TABLE 71 AMBULATORY SURGICAL CENTERS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 164
TABLE 72 LONG-TERM CARE FACILITIES: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 165
TABLE 73 DIAGNOSTIC IMAGING CENTERS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 166
TABLE 74 OUTPATIENT CLINICS: CATHETERS MARKET, BY COUNTRY/REGION,
2023–2030 (USD MILLION) 167
TABLE 75 OTHER END USERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 168
TABLE 76 CATHETERS MARKET, BY REGION, 2023–2030 (USD MILLION) 171
TABLE 77 NORTH AMERICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 78 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 79 NORTH AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 80 NORTH AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
(2023–2030) (THOUSAND UNITS) 174
TABLE 81 NORTH AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 174
TABLE 82 NORTH AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 83 NORTH AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 84 NORTH AMERICA: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 85 NORTH AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 176
TABLE 86 NORTH AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 176
TABLE 87 NORTH AMERICA: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 176
TABLE 88 NORTH AMERICA: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 177
TABLE 89 US: KEY MACROINDICATORS 178
TABLE 90 US: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 91 US: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 92 US: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 93 US: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 94 US: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 95 US: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 96 US: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 97 US: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 98 US: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 181
TABLE 99 US: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 182
TABLE 100 CANADA: KEY MACROINDICATORS 183
TABLE 101 CANADA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 102 CANADA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 103 CANADA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 104 CANADA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 105 CANADA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 106 CANADA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 107 CANADA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 108 CANADA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 109 CANADA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 186
TABLE 110 CANADA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 186
TABLE 111 EUROPE: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187
TABLE 112 EUROPE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 113 EUROPE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 114 EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE,
(2023–2030) (THOUSAND UNITS) 189
TABLE 115 EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 116 EUROPE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 117 EUROPE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 118 EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 119 EUROPE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 120 EUROPE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 121 EUROPE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 191
TABLE 122 EUROPE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 192
TABLE 123 GERMANY: KEY MACROINDICATORS 192
TABLE 124 GERMANY: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 125 GERMANY: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 126 GERMANY: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 127 GERMANY: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 128 GERMANY: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 129 GERMANY: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 130 GERMANY: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 131 GERMANY: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 132 GERMANY: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 195
TABLE 133 GERMANY: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 196
TABLE 134 UK: KEY MACROINDICATORS 196
TABLE 135 UK: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 136 UK: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 137 UK: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 138 UK: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 139 UK: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 140 UK: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 141 UK: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 142 UK: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 143 UK: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 199
TABLE 144 UK: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 200
TABLE 145 FRANCE: KEY MACROINDICATORS 200
TABLE 146 FRANCE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 147 FRANCE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 148 FRANCE: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 149 FRANCE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 150 FRANCE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 151 FRANCE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 152 FRANCE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 153 FRANCE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 154 FRANCE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 203
TABLE 155 FRANCE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 204
TABLE 156 SPAIN: KEY MACROINDICATORS 204
TABLE 157 SPAIN: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 158 SPAIN: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 159 SPAIN: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 160 SPAIN: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 161 SPAIN: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 162 SPAIN: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 163 SPAIN: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 164 SPAIN: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 165 SPAIN: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 207
TABLE 166 SPAIN: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 208
TABLE 167 ITALY: KEY MACROINDICATORS 208
TABLE 168 ITALY: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 169 ITALY: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 170 ITALY: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 171 ITALY: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 172 ITALY: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 173 ITALY: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 174 ITALY: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 175 ITALY: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 176 ITALY: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 211
TABLE 177 ITALY: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 212
TABLE 178 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 179 REST OF EUROPE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 180 REST OF EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 181 REST OF EUROPE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 182 REST OF EUROPE: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 183 REST OF EUROPE: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 184 REST OF EUROPE: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 185 REST OF EUROPE: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 186 REST OF EUROPE: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 215
TABLE 187 REST OF EUROPE: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 216
TABLE 188 ASIA PACIFIC: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217
TABLE 189 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 190 ASIA PACIFIC: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 191 ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE,
(2023–2030) (THOUSAND UNITS) 218
TABLE 192 ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 193 ASIA PACIFIC: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 194 ASIA PACIFIC: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 195 ASIA PACIFIC: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 196 ASIA PACIFIC: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 197 ASIA PACIFIC: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 198 ASIA PACIFIC: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 221
TABLE 199 ASIA PACIFIC: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 221
TABLE 200 JAPAN: KEY MACROINDICATORS 222
TABLE 201 JAPAN: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 202 JAPAN: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 203 JAPAN: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 204 JAPAN: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 205 JAPAN: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 206 JAPAN: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 207 JAPAN: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 208 JAPAN: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 209 JAPAN: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 225
TABLE 210 JAPAN: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 226
TABLE 211 CHINA: KEY MACROINDICATORS 226
TABLE 212 CHINA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 213 CHINA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 214 CHINA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 215 CHINA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 216 CHINA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 217 CHINA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 218 CHINA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 219 CHINA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 220 CHINA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 229
TABLE 221 CHINA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 230
TABLE 222 INDIA: KEY MACROINDICATORS 230
TABLE 223 INDIA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 224 INDIA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 231
TABLE 225 INDIA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 226 INDIA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 232
TABLE 227 INDIA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 228 INDIA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 229 INDIA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 230 INDIA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 231 INDIA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 233
TABLE 232 INDIA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 234
TABLE 233 AUSTRALIA: KEY MACROINDICATORS 235
TABLE 234 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 235 AUSTRALIA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 236 AUSTRALIA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 237 AUSTRALIA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 238 AUSTRALIA: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 236
TABLE 239 AUSTRALIA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 240 AUSTRALIA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 241 AUSTRALIA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 242 AUSTRALIA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 238
TABLE 243 AUSTRALIA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 238
TABLE 244 SOUTH KOREA: KEY MACROINDICATORS 239
TABLE 245 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 246 SOUTH KOREA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 247 SOUTH KOREA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 248 SOUTH KOREA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 249 SOUTH KOREA: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 250 SOUTH KOREA: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 251 SOUTH KOREA: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 252 SOUTH KOREA: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 253 SOUTH KOREA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 242
TABLE 254 SOUTH KOREA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 243
TABLE 255 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 256 REST OF ASIA PACIFIC: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 257 REST OF ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 258 REST OF ASIA PACIFIC: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 259 REST OF ASIA PACIFIC: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 260 REST OF ASIA PACIFIC: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 261 REST OF ASIA PACIFIC: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 262 REST OF ASIA PACIFIC: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 263 REST OF ASIA PACIFIC: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 247
TABLE 264 REST OF ASIA PACIFIC: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 247
TABLE 265 LATIN AMERICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 248
TABLE 266 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 267 LATIN AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 268 LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
(2023–2030) (THOUSAND UNITS) 250
TABLE 269 LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 270 LATIN AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 271 LATIN AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 272 LATIN AMERICA: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 273 LATIN AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 274 LATIN AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 275 LATIN AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 252
TABLE 276 LATIN AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 253
TABLE 277 BRAZIL: KEY MACROINDICATORS 253
TABLE 278 BRAZIL: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 279 BRAZIL: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 280 BRAZIL: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 281 BRAZIL: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 282 BRAZIL: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 283 BRAZIL: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 284 BRAZIL: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 285 BRAZIL: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 286 BRAZIL: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 257
TABLE 287 BRAZIL: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 257
TABLE 288 MEXICO: KEY MACROINDICATORS 258
TABLE 289 MEXICO: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 290 MEXICO: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 259
TABLE 291 MEXICO: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 259
TABLE 292 MEXICO: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 293 MEXICO: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 294 MEXICO: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 295 MEXICO: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 296 MEXICO: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 297 MEXICO: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 261
TABLE 298 MEXICO: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 262
TABLE 299 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 300 REST OF LATIN AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 301 REST OF LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 263
TABLE 302 REST OF LATIN AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 303 REST OF LATIN AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 264
TABLE 304 REST OF LATIN AMERICA: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 264
TABLE 305 REST OF LATIN AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 265
TABLE 306 REST OF LATIN AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 265
TABLE 307 REST OF LATIN AMERICA: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 266
TABLE 308 REST OF LATIN AMERICA: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 266
TABLE 309 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 267
TABLE 310 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 268
TABLE 311 MIDDLE EAST & AFRICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 268
TABLE 312 MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
(2023–2030) (THOUSAND UNITS) 269
TABLE 313 MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 269
TABLE 314 MIDDLE EAST & AFRICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 315 MIDDLE EAST & AFRICA: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 316 MIDDLE EAST & AFRICA: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 317 MIDDLE EAST & AFRICA: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 271
TABLE 318 MIDDLE EAST & AFRICA: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 271
TABLE 319 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 272
TABLE 320 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 272
TABLE 321 GCC COUNTRIES: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 273
TABLE 322 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 323 GCC COUNTRIES: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 274
TABLE 324 GCC COUNTRIES: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 274
TABLE 325 GCC COUNTRIES: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 275
TABLE 326 GCC COUNTRIES: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 275
TABLE 327 GCC COUNTRIES: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 275
TABLE 328 GCC COUNTRIES: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 276
TABLE 329 GCC COUNTRIES: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 276
TABLE 330 GCC COUNTRIES: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 276
TABLE 331 GCC COUNTRIES: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 277
TABLE 332 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 333 KINGDOM OF SAUDI ARABIA (KSA): CARDIOVASCULAR CATHETERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 334 KINGDOM OF SAUDI ARABIA (KSA): INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 335 KINGDOM OF SAUDI ARABIA (KSA): CENTRAL VENOUS CATHETERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 336 KINGDOM OF SAUDI ARABIA (KSA): UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 337 KINGDOM OF SAUDI ARABIA (KSA): URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 338 KINGDOM OF SAUDI ARABIA (KSA): DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 339 KINGDOM OF SAUDI ARABIA (KSA): SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 340 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 281
TABLE 341 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 281
TABLE 342 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 343 UNITED ARAB EMIRATES (UAE): CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282
TABLE 344 UNITED ARAB EMIRATES (UAE): INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 345 UNITED ARAB EMIRATES (UAE): CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 346 UNITED ARAB EMIRATES (UAE): UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 347 UNITED ARAB EMIRATES (UAE): URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 348 UNITED ARAB EMIRATES (UAE): DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 349 UNITED ARAB EMIRATES (UAE): SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 350 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 285
TABLE 351 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 285
TABLE 352 OTHER GCC COUNTRIES: CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 286
TABLE 353 OTHER GCC COUNTRIES: CARDIOVASCULAR CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 286
TABLE 354 OTHER GCC COUNTRIES: INTRAVENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 355 OTHER GCC COUNTRIES: CENTRAL VENOUS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 356 OTHER GCC COUNTRIES: UROLOGICAL CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 357 OTHER GCC COUNTRIES: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 358 OTHER GCC COUNTRIES: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 359 OTHER GCC COUNTRIES: SPECIALTY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 360 OTHER GCC COUNTRIES: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 289
TABLE 361 OTHER GCC COUNTRIES: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 289
TABLE 362 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 290
TABLE 363 REST OF MIDDLE EAST & AFRICA: CARDIOVASCULAR CATHETERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 364 REST OF MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 365 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS CATHETERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 366 REST OF MIDDLE EAST & AFRICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 367 REST OF MIDDLE EAST & AFRICA: URINARY CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 292
TABLE 368 REST OF MIDDLE EAST & AFRICA: DIALYSIS CATHETERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 292
TABLE 369 REST OF MIDDLE EAST & AFRICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 370 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY INDICATION,
2023–2030 (USD MILLION) 293
TABLE 371 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY END USER,
2023–2030 (USD MILLION) 293
TABLE 372 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CATHETERS MARKET 294
TABLE 373 CATHETERS MARKET: DEGREE OF COMPETITION 298
TABLE 374 CATHETERS MARKET: REGION FOOTPRINT 301
TABLE 375 CATHETERS MARKET: TYPE FOOTPRINT 302
TABLE 376 CATHETERS MARKET: INDICATION FOOTPRINT 303
TABLE 377 LIST OF KEY STARTUPS/SMES 306
TABLE 378 COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 307
TABLE 379 CATHETERS MARKET: PRODUCT APPROVALS/LAUNCHES,
JANUARY 2022–JULY 2025 310
TABLE 380 CATHETERS MARKET: DEALS, JANUARY 2022–JULY 2025 311
TABLE 381 CATHETERS MARKET: EXPANSIONS, JANUARY 2022–JULY 2025 312
TABLE 382 CATHETERS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 313
TABLE 383 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 314
TABLE 384 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 315
TABLE 385 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 318
TABLE 386 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025 319
TABLE 387 MEDTRONIC PLC: BUSINESS OVERVIEW 321
TABLE 388 MEDTRONIC PLC: PRODUCTS OFFERED 322
TABLE 389 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 324
TABLE 390 MEDTRONIC PLC: DEALS, JANUARY 2022–JULY 2025 324
TABLE 391 B. BRAUN SE: BUSINESS OVERVIEW 326
TABLE 392 B. BRAUN SE: PRODUCTS OFFERED 327
TABLE 393 B. BRAUN SE: DEALS, JANUARY 2022–JULY 2025 329
TABLE 394 B. BRAUN SE: EXPANSIONS, JANUARY 2022–JULY 2025 329
TABLE 395 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 331
TABLE 396 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 332
TABLE 397 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 334
TABLE 398 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2022–JULY 2025 334
TABLE 399 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2022–JULY 2025 334
TABLE 400 STRYKER CORPORATION: BUSINESS OVERVIEW 336
TABLE 401 STRYKER CORPORATION: PRODUCTS OFFERED 337
TABLE 402 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 338
TABLE 403 STRYKER CORPORATION: DEALS, JANUARY 2022–JULY 2025 338
TABLE 404 ABBOTT LABORATORIES: BUSINESS OVERVIEW 340
TABLE 405 ABBOTT LABORATORIES: PRODUCTS OFFERED 341
TABLE 406 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 342
TABLE 407 ABBOTT LABORATORIES: DEALS, JANUARY 2022–JULY 2025 343
TABLE 408 ABBOTT LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 343
TABLE 409 TERUMO CORPORATION: BUSINESS OVERVIEW 344
TABLE 410 TERUMO CORPORATION: PRODUCTS OFFERED 345
TABLE 411 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 346
TABLE 412 TERUMO CORPORATION: DEALS, JANUARY 2022–JULY 2025 347
TABLE 413 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 347
TABLE 414 COLOPLAST A/S: BUSINESS OVERVIEW 348
TABLE 415 COLOPLAST A/S: PRODUCTS OFFERED 349
TABLE 416 COLOPLAST A/S: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 351
TABLE 417 COLOPLAST A/S: EXPANSIONS, JANUARY 2022–JULY 2025 351
TABLE 418 CONVATEC GROUP PLC: BUSINESS OVERVIEW 352
TABLE 419 CONVATEC GROUP PLC: PRODUCTS OFFERED 354
TABLE 420 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 354
TABLE 421 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW 355
TABLE 422 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 356
TABLE 423 MERIT MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 358
TABLE 424 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2022–JULY 2025 358
TABLE 425 JOHNSON & JOHNSON: BUSINESS OVERVIEW 359
TABLE 426 JOHNSON & JOHNSON: PRODUCTS OFFERED 360
TABLE 427 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 361
TABLE 428 JOHNSON & JOHNSON: DEALS, JANUARY 2022–JULY 2025 363
TABLE 429 COOK: BUSINESS OVERVIEW 364
TABLE 430 COOK: PRODUCTS OFFERED 364
TABLE 431 COOK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 366
TABLE 432 COOK: DEALS, JANUARY 2022–JULY 2025 366
TABLE 433 EDWARDS LIFESCIENCES CORPORATION: BUSINESS OVERVIEW 367
TABLE 434 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 368
TABLE 435 NIPRO CORPORATION: BUSINESS OVERVIEW 369
TABLE 436 NIPRO CORPORATION: PRODUCTS OFFERED 370
TABLE 437 NIPRO CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 371
TABLE 438 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 372
TABLE 439 TELEFLEX INCORPORATED: PRODUCTS OFFERED 373
TABLE 440 TELEFLEX INCORPORATED: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JULY 2025 375
TABLE 441 TELEFLEX INCORPORATED: DEALS, JANUARY 2022–JULY 2025 375
TABLE 442 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 376
TABLE 443 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 377
TABLE 444 CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2022–JULY 2025 378
TABLE 445 HOLLISTER INCORPORATED: BUSINESS OVERVIEW 379
TABLE 446 HOLLISTER INCORPORATED: PRODUCTS OFFERED 379
TABLE 447 HOLLISTER INCORPORATED: EXPANSIONS, JANUARY 2022–JULY 2025 380
TABLE 448 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW 381
TABLE 449 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS OFFERED 382
TABLE 450 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 384
TABLE 451 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 385
TABLE 452 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JULY 2025 386
TABLE 453 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 387
TABLE 454 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 389
TABLE 455 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 389
LIST OF FIGURES
FIGURE 1 CATHETERS MARKET: MARKETS & REGIONS COVERED 35
FIGURE 2 RESEARCH DESIGN 40
FIGURE 3 PRIMARY SOURCES 43
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 45
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 46
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 46
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 47
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 48
FIGURE 9 SUPPLY-SIDE ANALYSIS: CATHETERS MARKET (2024) 49
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030) 50
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
FIGURE 12 DATA TRIANGULATION METHODOLOGY 53
FIGURE 13 CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 56
FIGURE 14 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 57
FIGURE 15 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 57
FIGURE 16 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 58
FIGURE 17 UROLOGICAL CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 58
FIGURE 18 URINARY CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 59
FIGURE 19 DIALYSIS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 59
FIGURE 20 SPECIALTY CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 60
FIGURE 21 CATHETERS MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION) 60
FIGURE 22 CATHETERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 61
FIGURE 23 GEOGRAPHIC SNAPSHOT: CATHETERS MARKET 62
FIGURE 24 INCREASING PREVALENCE OF CHRONIC DISEASES DRIVES GROWTH OF CATHETERS MARKET 63
FIGURE 25 CARDIOVASCULAR CATHETERS ACCOUNTED FOR LARGEST SHARE OF
NORTH AMERICAN MARKET IN 2024 64
FIGURE 26 ASIA PACIFIC TO GROW FASTEST IN MARKET THROUGHOUT FORECAST PERIOD 65
FIGURE 27 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 65
FIGURE 28 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
FORECAST PERIOD 66
FIGURE 29 CATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
FIGURE 30 CATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 75
FIGURE 31 PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–DECEMBER 2024) 84
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR CATHETER PATENTS
(JANUARY 2015–DECEMBER 2024) 85
FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 90
FIGURE 34 KEY BUYING CRITERIA FOR CATHETERS 91
FIGURE 35 CATHETERS MARKET: VALUE CHAIN ANALYSIS 95
FIGURE 36 CATHETERS MARKET: ECOSYSTEM ANALYSIS 96
FIGURE 37 CATHETERS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 97
FIGURE 38 CATHETERS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024 98
FIGURE 39 CATHETERS MARKET: REGIONAL GROWTH OPPORTUNITIES 170
FIGURE 40 NORTH AMERICA: CATHETERS MARKET SNAPSHOT 172
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN CATHETERS MARKET (2022−2024) 296
FIGURE 42 CATHETERS MARKET SHARE ANALYSIS OF KEY PLAYERS (2024) 297
FIGURE 43 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 299
FIGURE 44 CATHETERS MARKET: COMPANY FOOTPRINT 300
FIGURE 45 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 305
FIGURE 46 BRAND/PRODUCT COMPARATIVE ANALYSIS 308
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN CATHETERS MARKET, 2022−2024 308
FIGURE 48 EV/EBITDA OF KEY VENDORS 309
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 309
FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 315
FIGURE 51 MEDTRONIC PLC: COMPANY SNAPSHOT (2024) 322
FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2024) 327
FIGURE 53 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 332
FIGURE 54 STRYKER CORPORATION: COMPANY SNAPSHOT (2024) 337
FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 341
FIGURE 56 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 345
FIGURE 57 COLOPLAST A/S: COMPANY SNAPSHOT (2024) 349
FIGURE 58 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 353
FIGURE 59 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2024) 356
FIGURE 60 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 360
FIGURE 61 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024) 368
FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 370
FIGURE 63 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024) 373
FIGURE 64 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024) 377
FIGURE 65 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024) 382
FIGURE 66 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 385
FIGURE 67 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 388
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11